期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 56, 期 2, 页码 186-197出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2017-0019
关键词
circulating tumor cells; circulating tumor DNA; liquid biopsy; ovarian cancer; tumor biomarkers
Ovarian cancer remains the most lethal disease among gynecological malignancies despite the plethora of research studies during the last decades. The majority of patients are diagnosed in an advanced stage and exhibit resistance to standard chemotherapy. Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) represent the main liquid biopsy approaches that offer a minimally invasive sample collection. Both have shown a diagnostic, prognostic and predictive value in many types of solid malignancies and recent studies attempted to shed light on their role in ovarian cancer. This review is mainly focused on the clinical value of both CTCs and ctDNA in ovarian cancer and, more specifically, on their potential as diagnostic, prognostic and predictive tumor biomarkers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据